Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Labauge

Showing results (121-130 of 288) with videos related to

Pageof 29
Sort By:
European Neurology|May 8, 2007
Familial, adult onset form of leukoencephalopathy with brain stem and spinal cord involvement: inconstant high brain lactate and very slow disease progressionPierre Labauge, Etienne Roullet, Odile Boespflug-Tanguy, et al.
Multiple Sclerosis and Related Disorders|August 29, 2022
CSF β-amyloid is not a prognostic marker in multiple sclerosis patientsJustine Petitfour, Xavier Ayrignac, Nelly Ginestet, et al.
Plos One|January 30, 2016
The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX StudyMartine Roussel, Olivier Martinaud, Hilde Hénon, et al.
Journal of Neurology|May 12, 2012
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteriaDimitri Renard, Giovanni Castelnovo, Anne Wacongne, et al.
Journal of Neurology|May 28, 2013
Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patientElodie Nerrant, Mahmoud Charif, Anne-Sophie Ramay, et al.
Neurology. Genetics|June 15, 2026
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in <i>CSF1R</i>-Related DisorderXavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2013
COL4A1 mutation revealed by an isolated brain hemorrhageAstrid Corlobe, Elisabeth Tournier-Lasserve, Manuele Mine, et al.
Neurology|November 19, 2014
Clinical reasoning: A young woman with rapid mental deterioration and leukoencephalopathy: a treatable causeDamien Biotti, Maud Esteban-Mader, Eric Diot, et al.
Neurogenetics|May 29, 2009
U1 snRNA mis-binding: a new cause of CMT1BHervé Crehalet, Philippe Latour, Véronique Bonnet, et al.
Movement Disorders Clinical Practice|February 5, 2019
Cerebral Iron Accumulation Is Not a Major Feature of <i>FA2H</i>/SPG35Cecilia Marelli, Mustafa A Salih, Karine Nguyen, et al.
Pageof 29

Showing results (121-130 of 288) with videos related to

Sort By:
Pageof 29
European Neurology|May 8, 2007
Familial, adult onset form of leukoencephalopathy with brain stem and spinal cord involvement: inconstant high brain lactate and very slow disease progressionPierre Labauge, Etienne Roullet, Odile Boespflug-Tanguy, et al.
Multiple Sclerosis and Related Disorders|August 29, 2022
CSF β-amyloid is not a prognostic marker in multiple sclerosis patientsJustine Petitfour, Xavier Ayrignac, Nelly Ginestet, et al.
Plos One|January 30, 2016
The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX StudyMartine Roussel, Olivier Martinaud, Hilde Hénon, et al.
Journal of Neurology|May 12, 2012
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteriaDimitri Renard, Giovanni Castelnovo, Anne Wacongne, et al.
Journal of Neurology|May 28, 2013
Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patientElodie Nerrant, Mahmoud Charif, Anne-Sophie Ramay, et al.
Neurology. Genetics|June 15, 2026
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in <i>CSF1R</i>-Related DisorderXavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2013
COL4A1 mutation revealed by an isolated brain hemorrhageAstrid Corlobe, Elisabeth Tournier-Lasserve, Manuele Mine, et al.
Neurology|November 19, 2014
Clinical reasoning: A young woman with rapid mental deterioration and leukoencephalopathy: a treatable causeDamien Biotti, Maud Esteban-Mader, Eric Diot, et al.
Neurogenetics|May 29, 2009
U1 snRNA mis-binding: a new cause of CMT1BHervé Crehalet, Philippe Latour, Véronique Bonnet, et al.
Movement Disorders Clinical Practice|February 5, 2019
Cerebral Iron Accumulation Is Not a Major Feature of <i>FA2H</i>/SPG35Cecilia Marelli, Mustafa A Salih, Karine Nguyen, et al.
Pageof 29